ID: ALA5195407

Max Phase: Preclinical

Molecular Formula: C16H16FN5O2S

Molecular Weight: 361.40

Associated Items:

Representations

Canonical SMILES:  CNC(=O)c1nc2c(Nc3ccc(F)cc3OC(C)C)ncnc2s1

Standard InChI:  InChI=1S/C16H16FN5O2S/c1-8(2)24-11-6-9(17)4-5-10(11)21-13-12-15(20-7-19-13)25-16(22-12)14(23)18-3/h4-8H,1-3H3,(H,18,23)(H,19,20,21)

Standard InChI Key:  DPFZKILBVWKIDP-UHFFFAOYSA-N

Associated Targets(Human)

MAP kinase signal-integrating kinase 2 3518 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase-interacting serine/threonine-protein kinase MNK1 2071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Eukaryotic translation initation factor 600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 361.40Molecular Weight (Monoisotopic): 361.1009AlogP: 3.12#Rotatable Bonds: 5
Polar Surface Area: 89.03Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.18CX Basic pKa: 1.01CX LogP: 2.80CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.84

References

1. Xu W, Kannan S, Verma CS, Nacro K..  (2022)  Update on the Development of MNK Inhibitors as Therapeutic Agents.,  65  (2.0): [PMID:34533957] [10.1021/acs.jmedchem.1c00368]

Source